Enanta Pharmaceuticals | ENTA - Market Capitalization


Enanta Pharmaceuticals reported $297.9M in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 444.6B 59.91B Jun/2026
Amgen USD 195.44B 5.55B Jun/2026
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 11.5B 2.72B Jun/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
Biogen USD 31.9B 5B Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Enanta Pharmaceuticals USD 122M 98M Dec/2024
Gilead Sciences USD 156.86B 16.13B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Halozyme Therapeutics USD 9.28B 1.63B Jun/2026
Heron Therapeutics USD 238M 7M Dec/2025
Immunic USD 64M 23M Dec/2025
Incyte USD 22.65B 3.92B Jun/2026
Insmed USD 23.11B 12.19B Jun/2026
Ionis Pharmaceuticals USD 13.1B 642M Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Karyopharm Therapeutics USD 126M 9M Mar/2026
Ligand Pharmaceuticals USD 6.34B 2.35B Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Neurocrine Biosciences USD 16.95B 3.7B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 138.44B 15.37B Jun/2026
Roche Holding CHF 270B 3.66B Jun/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
Vertex Pharmaceuticals USD 126.07B 12.49B Jun/2026